JCI - Citations to Alzheimer disease therapy: Can the amyloid cascade be halted?

Citations to this article

Alzheimer disease therapy: Can the amyloid cascade be halted?

Published January 1, 2003
Citation Information: J Clin Invest. 2003;111(1):11-18. https://doi.org/10.1172/JCI17527.

View: Text | PDF

Total citations by year

Year:	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008	2007	2006	2005	2004	2003	2000	Total
Citations:	3	3	4	1	2	1	10	2	2	7	2	8	9	5	19	11	16	7	13	6	1	132

Citation information

Citations to this article (132)

Title and authors	Publication	Year
Alzheimer’s disease – the journey of a healthy brain into organ failure T Golde	Molecular Neurodegeneration	2022
Disease-Modifying Therapies for Alzheimer’s Disease: More Questions than Answers Golde TE	Neurotherapeutics	2022
Functional chicken-liver hydrolysates ameliorate insulin resistance and cognitive decline in streptozotocin-induced diabetic mice. Yeh WY, Lin YL, Yang WY, Chou CH, Wu YS, Chen YC	Poultry science	2022
From Hybrids to New Scaffolds: The Latest Medicinal Chemistry Goals in Multi-target Directed Ligands for Alzheimer's Disease. Alarcón-Espósito J, Mallea M, Rodríguez-Lavado J	Current neuropharmacology	2021
Can we learn lessons from the FDA’s approval of aducanumab? KY Liu, R Howard	Nature Reviews Neurology	2021
Novel strategies for the fight of Alzheimer’s disease targeting amyloid-β protein Y Xie, Y Wang, S Jiang, X Xiang, J Wang, L Ning	Journal of Drug Targeting	2021
γ-Secretase modulators exhibit selectivity for modulation of APP cleavage but inverse γ-secretase modulators do not CB Lessard, E Rodriguez, TB Ladd, LM Minter, BA Osborne, L Miele, TE Golde, Y Ran	Alzheimer's research & therapy	2020
Isoquinolines from national herb Corydalis tomentella and neuroprotective effect against lipopolysaccharide-induced BV2 microglia cells YM Wang, WZ Ming, H Liang, YJ Wang, YH Zhang, DL Meng	Bioorganic chemistry	2020
Alcohol consumption and cognitive function in elderly Japanese men AT Siddiquee, A Kadota, A Fujiyoshi, N Miyagawa, Y Saito, H Suzuki, K Kondo, H Yamauchi, T Ito, H Segawa, I Tooyama, K Miura, H Ueshima	Alcohol (Fayetteville, N.Y.)	2020
3,3-Difluoro-3,4,5,6-tetrahydropyridin-2-amines: potent and permeable BACE-1 inhibitors A Peschiulli, D Oehlrich, F Rombouts, A Vos, HJ Gijsen	Bioorganic & Medicinal Chemistry Letters	2020
Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer’s Disease ZH Wang, J Xiang, X Liu, SP Yu, FP Manfredsson, IM Sandoval, S Wu, JZ Wang, K Ye	Cell Reports	2019
A Closer Look into the Role of Protein Tau in the Identification of Promising Therapeutic Targets for Alzheimer’s Disease RI Khan, S Nirzhor, B Rashid	Brain Sciences	2018
Tramiprosate (Alzhemed) for Alzheimer's disease Malouf R, Collins H	The Cochrane Database of Systematic Reviews	2018
Pathological Role of Peptidyl-Prolyl Isomerase Pin1 in the Disruption of Synaptic Plasticity in Alzheimer’s Disease L Xu, Z Ren, FE Chow, R Tsai, T Liu, F Rizzolio, S Boffo, Y Xu, S Huang, CF Lippa, Y Gong	Neural plasticity	2017
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
Mouse Models for Drug Discovery G Proetzel, MV Wiles	Mouse Models for Drug Discovery	2016
In Vivo Detection of Amyloid Plaques by Gadolinium-Stained MRI Can Be Used to Demonstrate the Efficacy of an Anti-amyloid Immunotherapy MD Santin, ME Vandenberghe, AS Herard, L Pradier, C Cohen, T Debeir, T Delzescaux, T Rooney, M Dhenain	Frontiers in aging neuroscience	2016
Versatility of the Curcumin Scaffold: Discovery of Potent and Balanced Dual BACE-1 and GSK-3β Inhibitors RM di Martino, AD Simone, V Andrisano, P Bisignano, A Bisi, S Gobbi, A Rampa, R Fato, C Bergamini, DI Perez, A Martinez, G Bottegoni, A Cavalli, F Belluti	Journal of Medicinal Chemistry	2016
Resurrection of neurodegenerative diseases via stem cells S Nagaraj	Biomedical Research and Therapy	2016
The Protective Effects of Icariin against the Homocysteine-Induced Neurotoxicity in the Primary Embryonic Cultures of Rat Cortical Neurons XA Li, YS HO, L Chen, WL Hsiao	Molecules (Basel, Switzerland)	2016
Metal ion mediated transition from random coil to β-sheet and aggregation of Bri2-23, a natural inhibitor of Aβ aggregation M Luczkowski, RD Ricco, M Stachura, S Potocki, L Hemmingsen, D Valensin	Metallomics	2015
Theta and alpha EEG frequency interplay in subjects with mild cognitive impairment: evidence from EEG, MRI, and SPECT brain modifications DV Moretti	Frontiers in aging neuroscience	2015
Comparative studies using the Morris water maze to assess spatial memory deficits in two transgenic mouse models of Alzheimer's disease SR Edwards, AS Hamlin, N Marks, EJ Coulson, MT Smith	Clinical and Experimental Pharmacology and Physiology	2014
Dose-Dependent Inhibition of BACE-1 by the Monoterpenoid 2,3,4,4-Tetramethyl-5-methylenecyclopent-2-enone in Cellular and Mouse Models of Alzheimer’s Disease R Videira, P Castanheira, M Grãos, R Resende, L Salgueiro, C Faro, C Cavaleiro	Journal of Natural Products	2014
MER5101, a novel Aβ1-15:DT conjugate vaccine, generates a robust anti-Aβ antibody response and attenuates Aβ pathology and cognitive deficits in APPswe/PS1ΔE9 transgenic mice B Liu, JL Frost, J Sun, H Fu, S Grimes, P Blackburn, CA Lemere	The Journal of neuroscience : the official journal of the Society for Neuroscience	2013
Nanoparticulate flurbiprofen reduces amyloid-β42 generation in an in vitro blood-brain barrier model S Meister, I Zlatev, J Stab, D Docter, S Baches, RH Stauber, M Deutsch, R Schmidt, S Ropele, M Windisch, K Langer, S Wagner, H Briesen, S Weggen, CU Pietrzik	Alzheimer's research & therapy	2013
Suppressed Retinal Degeneration in Aged Wild Type and APPswe/PS1ΔE9 Mice by Bone Marrow Transplantation Y Yang, C Shiao, JF Hemingway, NL Jorstad, BR Shalloway, R Chang, CD Keene, J Priller	PloS one	2013
The missing link in the amyloid cascade of Alzheimer’s disease – Metal ions A Tiiman, P Palumaa, V Tõugu	Neurochemistry International	2013
Increase of theta frequency is associated with reduction in regional cerebral blood flow only in subjects with mild cognitive impairment with higher upper alpha/low alpha EEG frequency power ratio DV Moretti, A Prestia, G Binetti, O Zanetti, GB Frisoni	Frontiers in behavioral neuroscience	2013
Relevance of Magnetic Resonance Imaging for Early Detection and Diagnosis of Alzheimer Disease SJ Teipel, M Grothe, S Lista, N Toschi, FG Garaci, H Hampel	Medical Clinics of North America	2013
A necrodane monoterpenoid from Lavandula luisieri essential oil as a cell-permeable inhibitor of BACE-1, the β -secretase in Alzheimer's disease: Necrodane monoterpenoids from Lavandula luisieri inhibit β -secretase R Videira, P Castanheira, M Grãos, L Salgueiro, C Faro, C Cavaleiro	Flavour and Fragrance Journal	2013
Neurodegeneration in Alzheimer Disease: Role of Amyloid Precursor Protein and Presenilin 1 Intracellular Signaling M Nizzari, S Thellung, A Corsaro, V Villa, A Pagano, C Porcile, C Russo, T Florio	Journal of Toxicology	2012
A Plaque-Specific Antibody Clears Existing β-amyloid Plaques in Alzheimer's Disease Mice RB DeMattos, J Lu, Y Tang, MM Racke, CA DeLong, JA Tzaferis, JT Hole, BM Forster, PC McDonnell, F Liu, RD Kinley, WH Jordan, ML Hutton	Neuron	2012
Chemical Biology, Molecular Mechanism and Clinical Perspective of γ-Secretase Modulators in Alzheimer’s Disease B Bulic, J Ness, S Hahn, A Rennhack, T Jumpertz, S Weggen	Current neuropharmacology	2011
Apolipoprotein E: from lipid transport to neurobiology PS Hauser, V Narayanaswami, RO Ryan	Progress in Lipid Research	2011
Pyridazine-derived γ-secretase modulators Z Wan, A Hall, Y Jin, JN Xiang, E Yang, A Eatherton, B Smith, G Yang, H Yu, J Wang, L Ye, LF Lau, T Yang, W Mitchell, W Cai, X Zhang, Y Sang, Y Wang, Z Tong, Z Cheng, I Hussain, JD Elliott, Y Matsuoka	Bioorganic & Medicinal Chemistry Letters	2011
Alzheimer’s Disease: Current Status of Etiopathogenesis and Therapeutic Strategies MI Kh, LA Kassem	Pakistan Journal of Biological Sciences	2011
Moderate alcohol consumption and cognitive risk EJ Neafsey, MA Collins	Neuropsychiatric Disease and Treatment	2011
Cdk5: Multitasking between physiological and pathological conditions JP Lopes, P Agostinho	Progress in Neurobiology	2011
Precolumn derivatization followed by liquid chromatographic separation and determination of tramiprosate in rat plasma by fluorescence detector: Application to pharmacokinetics RN Rao, PK Maurya, DD Shinde, S Khalid	Journal of Pharmaceutical and Biomedical Analysis	2011
Epigenetic Aspects of Chronic Diseases HI Roach, F Bronner, RO Oreffo		2011
Inhibition of phosphodiesterase-4 reverses memory deficits produced by Aβ25–35 or Aβ1–40 peptide in rats YF Cheng, C Wang, HB Lin, YF Li, Y Huang, JP Xu, HT Zhang	Psychopharmacology	2010
Protein Misfolding Diseases P Chakrabarty, P Das, TE Golde	Protein Misfolding Diseases	2010
Cochrane Database of Systematic Reviews: Reviews N Shafiq, M Singh, S Kaur, P Khosla, S Malhotra, N Shafiq	Cochrane Database of Systematic Reviews: Reviews	2010
Alzheimer’s Disease: Fatty Acids We Eat may be Linked to a Specific Protection via Low-dose Aspirin MF Pomponi, G Gambassi, M Pomponi, C Masullo	Aging and disease	2010
Blue Books of Neurology H Wiendl, N Melzer, C Kleinschnitz, SG Meuth	Blue Books of Neurology	2010
An update on clinical proteomics in Alzheimer’s research MA Korolainen, TA Nyman, T Aittokallio, T Pirttilä	Journal of Neurochemistry	2010
His-tag binding by antibody C706 mimics β-amyloid recognition A Teplyakov, G Obmolova, G Canziani, Y Zhao, L Gutshall, SS Jung, GL Gilliland	Journal of molecular recognition : JMR	2010
Gelsolin as therapeutic target in Alzheimer's disease E Carro	Expert Opinion on Therapeutic Targets	2010
fac -{Ru(CO) 3 } 2+ Selectively Targets the Histidine Residues of the β-Amyloid Peptide 1-28. Implications for New Alzheimer's Disease Treatments Based on Ruthenium Complexes D Valensin, P Anzini, E Gaggelli, N Gaggelli, G Tamasi, R Cini, C Gabbiani, E Michelucci, L Messori, H Kozlowski, G Valensin	Inorganic Chemistry	2010
A small molecule inhibitor of signal peptide peptidase inhibits Plasmodium development in the liver and decreases malaria severity I Parvanova, S Epiphanio, A Fauq, TE Golde, M Prudêncio, MM Mota	PloS one	2009
Modeling familial British and Danish dementia HJ Garringer, J Murrell, L D’Adamio, B Ghetti, R Vidal	Brain structure & function	2009
Modular Synthesis of Heparan Sulfate Oligosaccharides for Structure−Activity Relationship Studies S Arungundram, K Al-Mafraji, J Asong, FE Leach, IJ Amster, A Venot, JE Turnbull, GJ Boons	Journal of the American Chemical Society	2009
MCP-1 involvement in glial differentiation of neuroprogenitor cells through APP signaling EG Vrotsos, PE Kolattukudy, K Sugaya	Brain Research Bulletin	2009
A Small Molecule Inhibitor of Signal Peptide Peptidase Inhibits Plasmodium Development in the Liver and Decreases Malaria Severity I Parvanova, S Epiphanio, A Fauq, TE Golde, M Prudêncio, MM Mota, G Langsley	PloS one	2009
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Pharmacogenomics in Drug Discovery and Development Q Yan		2008
Restraining tumor necrosis factor-alpha by thalidomide prevents the Amyloid beta-induced impairment of recognition memory in mice T Alkam, A Nitta, H Mizoguchi, K Saito, M Seshima, A Itoh, K Yamada, T Nabeshima	Behavioural Brain Research	2008
BRI2 (ITM2b) inhibits Abeta deposition in vivo J Kim, VM Miller, Y Levites, KJ West, CW Zwizinski, BD Moore, FJ Troendle, M Bann, C Verbeeck, RW Price, L Smithson, L Sonoda, K Wagg, V Rangachari, F Zou, SG Younkin, N Graff-Radford, D Dickson, T Rosenberry, TE Golde	The Journal of neuroscience : the official journal of the Society for Neuroscience	2008
Apolipoprotein E and cholesterol in aging and disease in the brain EP de Chaves, V Narayanaswami	Future Lipidology	2008
Early diagnosis and treatment of Alzheimer’s disease PR Solomon, CA Murphy	Expert Review of Neurotherapeutics	2008
Aβ1–42 reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: A quantitative analysis NA Evans, L Facci, DE Owen, PE Soden, SA Burbidge, RK Prinjha, JC Richardson, SD Skaper	Journal of Neuroscience Methods	2008
Discovery of a novel series of Notch-sparing γ-secretase inhibitors A Kreft, B Harrison, S Aschmies, K Atchison, D Casebier, DC Cole, G Diamantidis, J Ellingboe, D Hauze, Y Hu, D Huryn, M Jin, D Kubrak, P Lu, J Lundquist, C Mann, R Martone, W Moore, A Oganesian, A Porte, DR Riddell, J Sonnenberg-Reines, JR Stock, SC Sun, E Wagner, K Woller, Z Xu, H Zhou, JS Jacobsen	Bioorganic & Medicinal Chemistry Letters	2008
S14G-Humanin ameliorates Aβ25-35-induced behavioral deficits by reducing neuroinflammatory responses and apoptosis in mice J Miao, W Zhang, R Yin, R Liu, C Su, G Lei, Z Li	Neuropeptides	2008
l-3-n-Butylphthalide ameliorates β-amyloid-induced neuronal toxicity in cultured neuronal cells Y Peng, C Xing, CA Lemere, G Chen, L Wang, Y Feng, X Wang	Neuroscience Letters	2008
Soluble amyloid β oligomers may contribute to apoptosis of retinal ganglion cells in glaucoma H Yin, L Chen, X Chen, X Liu	Medical Hypotheses	2008
Alzheimer's Disease Research: Progress and Promises DD Christensen	CNS Spectrums	2008
5-Lipoxygenase gene disruption reduces amyloid-beta pathology in a mouse model of Alzheimer's disease O Firuzi, J Zhuo, CM Chinnici, T Wisniewski, D Praticò	The FASEB Journal	2007
Dendrimeric Aβ1–15 is an effective immunogen in wildtype and APP-tg mice TJ Seabrook, K Thomas, L Jiang, J Bloom, E Spooner, M Maier, G Bitan, CA Lemere	Neurobiology of Aging	2007
Changing the course of Alzheimer's disease: anti-amyloid disease-modifying treatments on the horizon DD Christensen	Primary care companion to the Journal of clinical psychiatry	2007
Amyloid Precursor Protein and Presenilin Involvement in Cell Signaling V Venezia, M Nizzari, P Carlo, A Corsaro, T Florio, C Russo	Neurodegenerative Diseases	2007
Targeting insulin-like growth factor-1 to treat Alzheimer's disease I Torres-Aleman	Expert Opinion on Therapeutic Targets	2007
Looking for novel ways to treat the hallmarks of Alzheimer's disease AJ Stewart, A Fox, BH Morimoto, I Gozes	Expert Opinion on Investigational Drugs	2007
Attenuated cytotoxicity but enhanced βfibril of a mutant amyloid β-peptide with a methionine to cysteine substitution XL Dai, YX Sun, ZF Jiang	FEBS Letters	2007
The Pathogenesis of Alzheimer's Disease and the Role of Aβ42 TE Golde	CNS Spectrums	2007
Alzheimer's Disease: Progress in the Development of Anti-amyloid Disease-Modifying Therapies DD Christensen	CNS Spectrums	2007
Amyloid Precursor Protein and Presenilin1 Interact with the Adaptor GRB2 and Modulate ERK 1,2 Signaling M Nizzari, V Venezia, E Repetto, V Caorsi, R Magrassi, MC Gagliani, P Carlo, T Florio, G Schettini, C Tacchetti, T Russo, A Diaspro, C Russo	The Journal of biological chemistry	2007
Pharmacological Mechanisms in Alzheimer's Therapeutics AC Cuello		2007
Insights into the mechanisms of action of anti-Abeta antibodies in Alzheimer's disease mouse models Y Levites, LA Smithson, RW Price, RS Dakin, B Yuan, MR Sierks, J Kim, E McGowan, DK Reed, TL Rosenberry, P Das, TE Golde	The FASEB Journal	2006
Boosting with intranasal dendrimeric Aβ1–15 but not Aβ1–15 peptide leads to an effective immune response following a single injection of Aβ1–40/42 in APP-tg mice TJ Seabrook, L Jiang, K Thomas, CA Lemere	Journal of Neuroinflammation	2006
Disease modifying therapy for AD? TE Golde	Journal of Neurochemistry	2006
Inhibitors of Rho-kinase modulate amyloid-β (Aβ) secretion but lack selectivity for Aβ42 S Leuchtenberger, MP Kummer, T Kukar, E Czirr, N Teusch, SA Sagi, R Berdeaux, CU Pietrzik, TB Ladd, TE Golde, EH Koo, S Weggen	Journal of Neurochemistry	2006
Intracranial adeno-associated virus-mediated delivery of anti-pan amyloid beta, amyloid beta40, and amyloid beta42 single-chain variable fragments attenuates plaque pathology in amyloid precursor protein mice Y Levites, K Jansen, LA Smithson, R Dakin, VM Holloway, P Das, TE Golde	The Journal of neuroscience : the official journal of the Society for Neuroscience	2006
Encyclopedia of Molecular Cell Biology and Molecular Medicine E Beutler	Encyclopedia of Molecular Cell Biology and Molecular Medicine	2006
NEURODEGENERATIVE DISEASES: New Concepts of Pathogenesis and Their Therapeutic Implications DM Skovronsky, VM Lee, JQ Trojanowski	Annual Review of Pathology: Mechanisms of Disease	2006
Plaques, Tangles, and Memory Loss in Mouse Models of Neurodegeneration JL Eriksen, CG Janus	Behavior Genetics	2006
Structure-Based Organic Synthesis of Drug Prototypes: A Personal Odyssey S Hanessian	ChemMedChem	2006
Longitudinal assessment of Alzheimer's β-amyloid plaque development in transgenic mice monitored by in vivo magnetic resonance microimaging N Braakman, J Matysik, SG van Duinen, F Verbeek, R Schliebs, HJ de Groot, A Alia	Journal of Magnetic Resonance Imaging	2006
γ-Secretase Modulation with Aβ42-Lowering Nonsteroidal Anti-Inflammatory Drugs and Derived Compounds E Czirr, S Weggen	Neurodegenerative Diseases	2006
Alzheimer Disease and Its Management: A Review MK Samanta, B Wilson, K Santhi, KP Kumar, B Suresh	American Journal of Therapeutics	2006
Abeta42 neurotoxicity in primary co-cultures: effect of apoE isoform and Abeta conformation AM Manelli, LC Bulfinch, PM Sullivan, MJ LaDu	Neurobiology of Aging	2006
Blockade of the insulin-like growth factor I receptor in the choroid plexus originates Alzheimer's-like neuropathology in rodents: New cues into the human disease? E Carro, JL Trejo, C Spuch, D Bohl, JM Heard, I Torres-Aleman	Neurobiology of Aging	2006
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ 42 in humans AM Fagan, MA Mintun, RH Mach, SY Lee, CS Dence, AR Shah, GN LaRossa, ML Spinner, WE Klunk, CA Mathis, ST DeKosky, JC Morris, DM Holtzman	Annals of Neurology	2006
Organofluorine Inhibitors of Amyloid Fibrillogenesis M Török, M Abid, SC Mhadgut, B Török	Biochemistry	2006
The amyloid precursor protein and its network of interacting proteins: physiological and pathological implications C Russo, V Venezia, E Repetto, M Nizzari, E Violani, P Carlo, G Schettini	Brain research. Brain research reviews	2005
Toward the Validation of Functional Neuroimaging as a Potential Biomarker for Alzheimer?s Disease: Implications for Drug Development A Pupi, L Mosconi, FM Nobili, S Sorbi	Molecular Imaging and Biology	2005
Bringing amyloid into focus TE Golde, BJ Bacskai	Nature Biotechnology	2005
STIGMATIZATION IN ALZHEIMER'S DISEASE RESEARCH ON AFRICAN AMERICAN ELDERS EC Holston	Issues in Mental Health Nursing	2005
Intraneuronal Aβ accumulation and origin of plaques in Alzheimer's disease GK Gouras, CG Almeida, RH Takahashi	Neurobiology of Aging	2005
Studies on the mechanism of action of a proline-rich polypeptide complex (PRP): Effect on the stage of cell differentiation A Kubis, E Marcinkowska, M Janusz, J Lisowski	Peptides	2005
Synergistic amplification of β-amyloid- and interferon-γ-induced microglial neurotoxic response by the senile plaque component chromogranin A G Twig, SA Graf, MA Messerli, PJ Smith, SH Yoo, OS Shirihai	American journal of physiology. Cell physiology	2005
Apoptotic Cell Death and Amyloid Precursor Protein Signaling in Neuroblastoma SH-SY5Y Cells V Venezia, C Russo, E Repetto, M Nizzari, E Violani, P Carlo, B Marchetti, G Schettini	Annals of the New York Academy of Sciences	2004
BACE1 Overexpression Regulates Amyloid Precursor Protein Cleavage and Interaction with the ShcA Adapter E Repetto, C Russo, V Venezia, M Nizzari, RM Nitsch, G Schettini	Annals of the New York Academy of Sciences	2004
Search Strategies Used by APP Transgenic Mice During Navigation in the Morris Water Maze C Janus	Learning & Memory	2004
Apoptotic mechanisms in Alzheimer neurofibrillary degeneration: cause or effect? DW Dickson	Journal of Clinical Investigation	2004
Genomic characterization of Alzheimer’s disease and genotype-related phenotypic analysis of biological markers in dementia R Cacabelos	Pharmacogenomics	2004
Future directions in the treatment of Alzheimer’s disease R Bullock	Expert Opinion on Investigational Drugs	2004
Neuroprotective effect of cannabidiol, a non-psychoactive component from Cannabis sativa, on beta-amyloid-induced toxicity in PC12 cells T Iuvone, G Esposito, R Esposito, R Santamaria, MD Rosa, AA Izzo	Journal of Neurochemistry	2004
Insulin-like growth factor I and Alzheimer´s disease: therapeutic prospects? E Carro, I Torres-Aleman	Expert Review of Neurotherapeutics	2004
Species-specific immune response to immunization with human versus rodent Aβ peptide TJ Seabrook, JK Bloom, M Iglesias, ET Spooner, DM Walsh, CA Lemere	Neurobiology of Aging	2004
Neuroprotective strategies in Alzheimer’s disease FM Longo, SM Massa	NeuroRX	2004
Inhibitors of beta-amyloid aggregation: still an issue of structure and function? P Talaga	Drug Discovery Today: Therapeutic Strategies	2004
Oligomerization of Alzheimer's -Amyloid within Processes and Synapses of Cultured Neurons and Brain RH Takahashi	The Journal of neuroscience : the official journal of the Society for Neuroscience	2004
Cognitive Enhancing Drugs JJ Buccafusco		2004
Consistent Lowering of Abeta42 levels In Vitro and In Vivo by Commonly Used NSAIDs and Enantiomers of Flurbiprofen: Implications for Alzheimer’s Disease Therapy Jason L. Eriksen, Sarah A. Sagi, Tawnya E. Smith, Sascha Weggen, Pritam Das, D.C. McLendon, Victor V. Ozols, Kevin W. Jessing, Kenton H. Zavitz, Edward H. Koo, Todd E. Golde	Journal of Clinical Investigation	2003
Series Introduction: Neurodegeneration: What is it and where are we? S Przedborski, M Vila, V Jackson-Lewis	Journal of Clinical Investigation	2003
Alzheimer’s disease: from molecular pathogenesis to innovative therapies E Scarpini, F Cogiamanian	Expert Review of Neurotherapeutics	2003
Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease Christoph Hock, Uwe Konietzko, Johannes R Streffer, Jay Tracy, Andri Signorell, Britta Müller-Tillmanns, Ulrike Lemke, Katharina Henke, Eva Moritz, Esmeralda Garcia, M Axel Wollmer, Daniel Umbricht, Dominique J F de Quervain, Marc Hofmann, Alessia Maddalena, Andreas Papassotiropoulos, Roger M Nitsch	Neuron	2003
Partial Purification and Characterization of γ-Secretase from Post-mortem Human Brain MR Farmery, LO Tjernberg, SE Pursglove, A Bergman, B Winblad, J Näslund	The Journal of biological chemistry	2003
Cholesterol: from heart attacks to Alzheimer's disease RL Raffaï, KH Weisgraber	Journal of lipid research	2003
Kirk-Othmer Encyclopedia of Chemical Technology GR Lenz, HG Schoepke, TC SPAULDING	Kirk-Othmer Encyclopedia of Chemical Technology	2000

Advertisement